HBM9161

· Harbour BioMed (Guangzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for HBM9161, covering 2021-02-10 to 2026-04-28. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP [Phase 2, Phase 3]